Compare RXST & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RXST | ACRE |
|---|---|---|
| Founded | 1997 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.2M | 240.8M |
| IPO Year | 2021 | 2011 |
| Metric | RXST | ACRE |
|---|---|---|
| Price | $5.32 | $4.36 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 10 | 4 |
| Target Price | ★ $9.78 | $5.38 |
| AVG Volume (30 Days) | ★ 733.5K | 266.9K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 11.58% |
| EPS Growth | N/A | ★ 26.17 |
| EPS | N/A | ★ 1.35 |
| Revenue | N/A | ★ $54,833,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.06 | $16.28 |
| P/E Ratio | ★ N/A | $3.24 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.48 | $4.14 |
| 52 Week High | $13.22 | $5.89 |
| Indicator | RXST | ACRE |
|---|---|---|
| Relative Strength Index (RSI) | 35.45 | 39.92 |
| Support Level | $5.26 | $4.33 |
| Resistance Level | $5.92 | $4.69 |
| Average True Range (ATR) | 0.38 | 0.10 |
| MACD | -0.16 | -0.03 |
| Stochastic Oscillator | 0.76 | 22.22 |
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.
Ares Commercial Real Estate Corp is a specialty finance company and a real estate investment trust mainly engaged in originating and investing in commercial real estate (CRE) loans and related investments. It operates in one segment, namely originating and managing a diversified portfolio of CRE debt-related investments. The company recognizes the majority of its revenues in the form of interest income, which it receives from loans.